Hubble Bioscience, Inc. — Form D
Hubble Bioscience, Inc. of PORTLAND, OR, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-13. The offering totals $500K, of which $50K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-01-13
- Form: D
- Accession: 0001799010-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $50K
- Remaining: $450K
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2019-12-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-357763
Issuer
- Name: Hubble Bioscience, Inc.
- CIK: 0001799010
- Entity type: Corporation
- Jurisdiction: OREGON
- Incorporated: 2019
- Address: 3125 SE BELMONT STREET, PORTLAND, OR, 97214
- Phone: 971-258-1152
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| PIPER J DOBNER | Director | Portland, OR |
| ANDREA M MCBETH | Director | Portland, OR |
| PIPER J DOBNER | Executive Officer | Portland, OR |
| ANDREA M MCBETH | Executive Officer | Portland, OR |
| PIPER J DOBNER | Promoter | Portland, OR |
| ANDREA M MCBETH | Promoter | Portland, OR |
More